When 13-year-old Will Moore began to have severe reactions to foods that had previously been safe for him, his family turned to James P. Franciosi, MD, Gastroenterology Division Chief. Dr. Franciosi had diagnosed Will’s younger brother, Charlie, with eosinophilic esophagitis (EoE) when he was just nine months old. Their mother, Laura, remembers the EoE journey with Will, citing his status as a patient of Dr. Franciosi as a positive aspect of dealing with the disease. She explained, “Dr. Franciosi is very passionate about helping kids with EoE and excited for all the recent advances in the field, including biologic therapies and new ways to test patients.”
A precision medicine pilot research project studying the right drug and dose for pediatric patients with EoE and upper gastrointestinal tract disorders — along with the extraordinary care they’d received for more than a decade — moved the Moore family to make a gift in support of Dr. Franciosi and his team. They are searching for the key to determining the maximal efficacy and minimal toxicity for individual patients with EoE.